Beginning Cash: The amount of cash reported by the company on its previous statement.
Upstream Bio, Inc. (UPB) had Beginning Cash of $326.09M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$2.85M |
|
$-143.44M |
|
-- |
|
$2.85M |
|
$163.22M |
|
$-160.36M |
|
$16.92M |
|
$-143.44M |
|
$-143.44M |
|
$-143.44M |
|
$-143.44M |
|
$-143.44M |
|
$-143.44M |
|
$-160.36M |
|
$-161.68M |
|
53.85M |
|
53.85M |
|
$-2.66 |
|
$-2.66 |
|
| Balance Sheet Financials | |
$351.80M |
|
$0.56M |
|
$1.98M |
|
$353.77M |
|
$13.45M |
|
-- |
|
$0.55M |
|
$14.00M |
|
$339.77M |
|
$339.77M |
|
$339.77M |
|
54.24M |
|
| Cash Flow Statement Financials | |
$-133.28M |
|
$-93.48M |
|
$2.44M |
|
|
Beginning Cash |
$326.09M |
$101.77M |
|
$-224.31M |
|
$10.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
26.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-5618.81% |
|
-5618.81% |
|
-5664.85% |
|
-5026.03% |
|
-5026.03% |
|
$-133.44M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
4.27 |
|
85.43 |
|
-42.22% |
|
-42.22% |
|
-40.55% |
|
-42.22% |
|
$6.26 |
|
$-2.48 |
|
$-2.47 |
|